Copyright 2000 Federal News Service, Inc. 
  
Federal News Service 
February 10, 2000, Thursday 
SECTION: PREPARED TESTIMONY 
LENGTH: 5772 words 
HEADLINE: 
PREPARED TESTIMONY OF THE HEALTH CARE LIABILITY ALLIANCE 
  
BEFORE 
THE HOUSE COMMITTEE ON WAYS AND MEAN SUBCOMMITTEE ON HEALTH 
  
SUBJECT - "THE PREVALENCE AND NATURE OF MEDICAL ERRORS IN THE 
HEALTH CARE SYSTEM AND STRATEGIES FOR REDUCTION OF ERRORS" 
BODY: 
 Executive Summary 
The Institute 
of Medicine (IOM) Report makes a significant contribution to the efforts members 
of the Health Care Liability Alliance (HCLA) and others in the health care field 
are making to improve the quality of patient care because it recognizes that: 
a. the focus should be on systems, not individuals, and that prevention 
of future errors is more important than retrospective faultfinding; 
b. 
reporting of adverse events is necessary to prevent future errors; and c. 
reporting systems currently are not working adequately because the tort 
litigation system discourages reporting of errors. 
Because of its 
concern for the effect the tort system has on the quality of care, HCLA welcomes 
the IOM Report. The IOM Report takes the nation a significant step forward by 
recognizing that the tort system is a major barrier to improving the quality of 
care. That underlying conclusion provides the basis for meaningful federal 
tort reforms. The IOM Report recommends expansion of the 
immunity and protection provided for peer review materials although it 
inconsistently recommends that confidentiality not be provided for reports of 
serious adverse events. The members of HCLA believe that efforts to improve 
quality are not impeded by the absence of centralized reporting. Barriers to 
reporting are raised by a lack of confidentiality and the waste, randomness, and 
injustice of the tort litigation system. While the IOM Report recognizes these 
barriers, it does not recommend cures for them. HCLA's recommendations address 
the problems identified but not addressed by the IOM Report.HCLA, while not 
agreeing with the conclusions of The Harvard Medical Practice Study, does 
recognize the underlying premise of the study. Patient safety and quality of 
care must be paramount in the health care system. We should, as a health care 
system and as a society, endeavor to eliminate avoidable injures. We must focus 
on what can be done to identify, reduce and eliminate injuries. 
HCLA 
recommends, therefore, that to promote reporting and analysis of adverse event 
reports and to enable providers and others to better collaborate on quality 
improvement efforts, Congress should: 
a. Focus on doing only what is 
necessary, at the federal level, to empower the health care providers to address 
this problem by allowing appropriate information regarding adverse events to 
quickly reach the people in the health care system who will use such information 
to improve patient safety. 
b. Recognize that creation of a national 
center for collection of adverse event reports will not yield its intended 
result -- a reduction in such events. 
c. Enact legislation providing 
confidentiality protection for safety and quality reports and efforts, such as 
peer review. 
d. Enact into law the tort reforms 
embodied in HCLA's model bill already proven successful in the MICRA legislation 
in California. 
The IOM is to be congratulated on its endeavors to 
improve the nation's health care system by bringing its focus on the incidence 
of medical errors. The I0M Report clearly identifies the obstacles to improving 
patient safety. HCLA supports the IOM Report's conclusion that the current 
methods of dealing with medical errors are counterproductive. HCLA believes a 
more direct approach is necessary. 
Federal reform of the tort system is 
the sine qua non of that approach. 
For additional information, please 
visit the HCLA website: 
www.hcla.org 
************* 
Statement of the Health Care Liability Alliance 
The Health Care 
Liability Alliance (HCLA) is a coalition of more than 30 organizations committed 
to reform of the health care litigation system to enhance its fairness, 
timeliness, and cost-effectiveness. HCLA's members are organizations and 
associations of physicians, hospitals, blood banks, health device manufacturers, 
health care insurers, pharmaceutical manufacturers, and biotechnology companies. 
HCLA applauds the Chairman's timely leadership in connection with the 
issue of' patient safety. We appreciate the opportunity to submit our views 
regarding the report of the Institute of Medicine (IOM) entitled "To Err is 
Human: Building a Safer Health System." We look forward to working with the 
Chairman, members of the Committee, and their staff as Congress debates this 
important issue. 
Because of its concern for the effect the tort system 
has on the quality of care, HCLA welcomes the IOM Report. The Report makes a 
significant contribution by recognizing that the tort system is a major barrier 
to improving the quality of care. That underlying conclusion provides the basis 
for meaningful tort reforms. 
INTRODUCTION 
The 
tort system as it now operates in this country increases health care costs by 
forcing providers to practice defensive medicine and by imposing inordinate 
litigation costs on the health care system. These costs are borne by patients, 
people with insurance, people who are trying to buy insurance, people who need 
care, and taxpayers--through higher health care costs, higher insurance 
premiums, higher taxes, and reduced access to care. 
The tort system does 
not provide benefits that justify these costs. It does not carry. out its 
intended functions. It does not establish a rational standard of care. Findings 
of liability, made in court with hindsight and with the benefit of leisurely 
contemplation that rarely are possible in the actual delivery of care, often do 
not provide an accurate standard of medical conduct. As one expert on the tort 
system has summarized this situation, "The fundamental problem of tort 
liability, especially in the areas of products liability and medical 
malpractice, stems from the unpredictability of its imposition."1 
This 
retroactive, case-by-case, and arbitrary standard making has caused doctors to 
practice defensive medicine-- to order medical procedures out of a perceived 
need to have a defense available if there should be an adverse event. Cesarean 
delivery rates provide one example. 
Because juries awarded large 
recoveries for birth injuries where obstetricians did not perform a Cesarean 
section, doctors have performed them more often than they otherwise would have. 
Cesarean rates rose from 4.5 per 100 births in 1965 to 24.1 in 1986.2 
The essentially unlimited power of juries to award non-economic damages 
results in verdicts that are not just and that when publicized whet the appetite 
of trial lawyers and traumatize providers. In many cases, (enough to engender 
disdain for the litigation system and fear on the part of the provider), there 
is no logical or medical connection between the provider's action and liability 
or between the injury and the amount of damages awarded. 
The Harvard 
Study of hospital care in New York itself demonstrated that the filing of claims 
was not correlated to negligence.3 In a follow-on study of claims of malpractice 
filed by patients in the Study, several of the authors concluded that "the 
severity of the patient's disability, not the occurrence of an adverse event or 
an adverse event due to negligence, was predictive of payment to the 
plaintiff."4 In other words, the amount patients recovered through the tort 
system was a function of their health condition, not any negligence by the 
health care system. The authors concluded more generally, therefore, that "the 
standard of medical negligence performs poorly in malpractice litigation."5 
The tort system thus presents a provider with the random risk of 
catastrophic financial injury. This causes some providers to quit practice and 
others to limit their practice, reducing patients' access to care, particularly 
in inner-city and rural areas. Most of those who continue to practice are forced 
to engage in defensive medicine. This results in more medical interventions for 
patients, as the increased rate of Cesarean deliveries demonstrates, thereby 
adding costs and putting patients at greater risk. It is estimated that 
defensive medicine costs at least $50 billion per year. 
At the same time, the litigation system does not provide fair and timely 
compensation for injured patients. They must wait on average 3 1/2 years for 
resolution of their claims by the litigation system. If they prevail, they 
typically must give 33-60% of any recovery to their lawyers in contingency fees. 
Only 28 percent of the amount spent to provide insurance coverage actually goes 
to victims; the rest is spent in transaction costs and in operating the tort 
litigation system.7 The tort system imposes a 72% tax on patients and providers. 
Because of the threatening and contentious climate it creates, the 
litigation system, rather than protecting patients, is actually impeding efforts 
to improve the quality of care. It makes it difficult for providers to 
acknowledge mistakes. It deters open discussion of possible errors. And it 
discourages providers from filing reports, seeking assistance, and collaborating 
with other providers and experts to improve quality. 
The money spent on 
defensive medicine and litigation expenses could be better used to improve the 
quality of care and access to it. The energy and focus that the present system 
channels into litigation- related and litigation-induced actions should be 
redirected into developing better quality control systems and innovative ways of 
delivering care. 
INSTITUTE OF MEDICINE REPORT 
With one 
exception, the IOM Report avoids inflated rhetoric. The exception is its 
statement that as many as 98,000 people may die annually because of medical 
error. This figure is extrapolated in ways that are not explained from 71 deaths 
that the Harvard Study of the medical records of 31,429 patients discharged from 
51 New York hospitals in 1984 said were attributable to negligence.8 This 
extrapolation has no scientific basis, as the authors of the Study themselves 
have recognized.9 
The Harvard Study, moreover, suffered from 
methodological flaws, and its results have not been duplicated. The reviewers 
who determined which records reflected negligence agreed in only 10% of the 
cases. In an effort to confirm findings that rest on this shaky foundation, a 
second set of reviewers examined a subset of 318 of the records. Apparently they 
did not reach the same conclusions on individual records that were attributed to 
the primary set of reviewers.10 
The authors of the Harvard Study also 
applied their methodology to patients in Colorado and Utah hospitals in 1992. 
Extrapolating the results of this study, the authors concluded that 44,000 
deaths were caused nationwide by medical error. The IOM Report finds this, and 
the unexplained figure of 98,000 deaths, to represent a range.11 The more recent 
study, however, could equally be seen as an indication that health care improved 
in the 8 years after the New York study, that better care is provided in 
Colorado and Utah, or, since the results of the Harvard Study could not be 
duplicated, that the parameters of the Study are vague and the methodology is 
flawed. 
It is not our purpose here to discuss the weaknesses of the 
Harvard Study or the exaggerated extrapolations that have been made from it. 
Patient safety and quality care should not be a numbers game. We should, as a 
health care system and as a society, endeavor to eliminate avoidable injuries. 
In doing so we must remember, as the Harvard Study reminds us, medical 
intervention is inherently risky and is provided by people. 
People are 
only human, and the title chosen for the IOM report reflects the reality this 
presents; "To Err is Human." Because we are dealing with medical intervention by 
human beings, we must focus on what we can do together to reduce the number of 
unnecessary injuries suffered during the delivery of health care services. 
The IOM Report makes a vital contribution to this effort by its 
recognition and discussion of the three interrelated factors that now impede 
efforts to improve patient safety. 
First, it emphasizes that the problem 
is not "bad apples,"13 although there are some "bad people" and they must be 
weeded out. Mistakes are often caused, or are not prevented, by system (both 
technical and organizational) failures. As the Report suggests, because 
providers are only human, they need systems to help them avoid mistakes; but we 
cannot let reliance on systems dull the special intelligence that humans posses 
or lull them into lethargic complacency. 
The focus must be on developing 
systems that avoid future mistakes and not on attempting to pin blame for past 
conduct on an individual. This important observation leads the Report to balance 
public policy in favor of error prevention and away from faultfinding: "When an 
error occurs, blaming an individual does little to make the system safer and 
prevent someone else from committing the same error."14 "Although a punitive 
response may be appropriate in some cases (e.g., deliberate malfeasance), it is 
not an effective way to prevent recurrence."15 
Secondly, the Report 
emphasizes the need to report information about adverse events or potential 
adverse events in order to identify patterns of conduct that threaten safety and 
to assess the success of corrective actions. It correctly recognizes that 
reporting is essential to the primary goal of prevention. The Report provides a 
comprehensive summary of the numerous and varied reporting systems that are 
currently in effect. 
Thirdly, and most importantly, the Report 
recognizes that there is a critical and common element or impediment that 
prevents all the reporting systems, regardless of how they are structured, from 
collecting the information they need. That impediment is the tort system. 
Participants and witnesses to an adverse event are reluctant to report 
it (even if required by law to do so) out of fear that doing so will trigger or 
support a tort claim. The irrationality of the litigation system and the 
randomness of its results trigger a defensive reaction. Fear of being enmeshed 
in that system, even if one is ultimately found not to be liable, deters 
reporting. 
As the Report concludes, "Patient safety is also hindered 
through the liability system and the threat of malpractice, which discourages 
the disclosure of errors. The discoverability of data under legal proceedings 
encourages silence about errors committed or observed."16 As a result, it finds 
"All reporting systems, whether mandatory or voluntary, are perceived to suffer 
from underreporting. Indeed, some experts assert that all reporting is 
fundamentally voluntary since even mandated reporting can be avoided .... The 
volume of reporting is influenced by more factors than simply whether reporting 
is mandatory or voluntary .... One factor is related to confidentiality."17 
"Thus," the Report concludes, "the prominence of litigation can be a substantial 
deterrent to the development and maintenance of the reporting systems discussed 
in this report. 
"18 
It is refreshing that the IOM Report 
recognizes this problem. It is important to the debate that it does so. The tort 
system impedes efforts to improve health care by deterring the reporting of data 
needed to make improvements in the health care system.Recognition of this fact 
by The IOM should provide the needed impetus for addressing this basic problem. 
As the Report recognizes, the tort system deters reporting even where 
confidentiality is promised. There is concern that confidential data will leak. 
There is also fear that what is confidential today may not be protected 
tomorrow. The Report cites the powerful example of the continuing political 
pressure to "open up" the National Practitioner Data Bank. 19 Providers are 
concerned that the constant political pressure eventually will be successful, 
leading to a breach not only of a particular data source but also inserting the 
opening wedge for a more general release. 
Confidentiality of adverse 
event reports, therefore, is necessary to develop an effective reporting system 
that will permit identification of safety problems and permit assessment of 
remedial actions. But there is on-going concern that even confidential reports 
will be fed into the litigation system--by leaks or by surrender to political 
pressure to remove the confidentiality protection. Confidentiality of reports is 
necessary to improve reporting, but it is not sufficient. The tort system also 
must be reformed. 
TWO REFORMS THAT ARE NEEDED 
The findings of 
the IOM Report, therefore, confirm the need for a combination of two reforms: 
confidential protection for adverse event reports and a reformed tort system. 
Confidential reporting 
It is important that Congress act on the 
findings of the Report by protecting the confidentiality of reports made of 
adverse events or of problems that could lead to adverse events. 
The 
Report in several places emphasizes the need for reporting to be confidential. 
It appears, in fact, to call for Federal legislation to protect confidentiality 
of all reports although it also makes an inconsistent recommendation that would 
deny confidentiality to reports of adverse events leading to serious injury. The 
Report recommends Federal legislation to "extend peer review protections to data 
related to patient safety and quality improvement that are collected and 
analyzed by health care organizations for internal use or shared with others 
solely for purposes of improving safety and quality."20 
As the Report's 
discussion of peer review protection reflects, the nature and the scope of the 
current protection varies widely from state to state.21 Not only does the scope 
of the protection afforded by each state differ greatly, but in some instances 
the sharing of peer review materials with third parties engaged in health care 
quality efforts, such as The Joint Commission on Accreditation of Healthcare 
Organizations (JCAHO), has been held to waive any confidentiality protection.22 
Moreover, the efficacy of these state protections is further undermined by 
uncertainty surrounding the application of the peer review privilege should the 
parties be drawn into federal court. This occurs, for instance,in actions 
brought under a Federal statute with related medical malpractice claims under 
state law (i.e., pendent state claims). 
As the Report recognizes, health 
care providers must have confidence that the peer review privilege will be 
applied with consistency and predictability if they are to come forward with 
information regarding medical errors.23 The discussion in the Report focuses on 
immunity and protection of peer review materials and deliberations from 
discovery. In urging that the protection be expanded, the Report at a minimum 
recommends that quality and safety information derived from reports or from 
investigation (the main areas now protected in different ways by peer review 
statutes) be protected from use in litigation and from public dissemination. The 
information derived through the peer review process may involve the "most 
serious adverse events"; thus this recommendation calls for the appropriate 
confidential treatment of such information. 
However, the Report also 
says that such information should be available for public consumption and that 
only reports of events other than the "most serious adverse events" should have 
confidentiality protection.23 We discuss this misplaced, and internally 
inconsistent, position below. The important fact is that the Report finds that 
confidentiality is necessary for effective reporting and patient safety 
improvements and recommends in, at least one place, across-the- board 
confidentiality. 
Tort reform 
Even where 
confidentiality would be provided, but particularly where it would not, 
reporting and improvements in the health care system quality can best be 
advanced by reforming the tort system to protect providers from random and 
excessive judgments. HCLA urges Congress to enact the tort 
reforms embodied in its proposed legislation which is modeled on the 
MICRA reforms enacted in California in 1975. 
These reforms would 
preserve the ability of injured patients to obtain compensation for their 
economic injury and to recover reasonable non- economic damages. They would: 1) 
encourage non-judicial resolution of claims and ensure that plantiffs' lawyers 
did not capture an excessive contingency fee from their clients; 2) prevent 
plaintiffs from obtaining double recovery (collateral source rule); 3) limit 
noneconomic damages to a reasonable amount ($250,000); 4) 
require plaintiffs to bring any action in a reasonable time after the injury 
occurs or is recognized (statute of limitations and statute of repose); 5) 
protect any particular defendant from paying a larger percentage of any recovery 
than is warranted by his/her conduct (joint and several liability). 
Passage of these measures will restore a measure of balance to the tort 
system, give providers more faith in the system, and therefore facilitate 
reporting--which ultimately will result in greater patient safety. 
As 
the IOM Report recognizes, patient safety is not adequately served by the 
present system. If the tort system in its current state were adequately 
protecting patient safety, the Report would not have been necessary. The tort 
system is not only not the answer; it is the barrier to the enhanced quality 
systems that the Report correctly finds are the best way to improve safety. The 
underlying, if unarticulated, theme of the Report, therefore, is that 
tort reform is necessary to improve the quality of health care 
in this country. 
ACTIONS THAT SHOULD NOT BE TAKEN 
The Report 
correctly concludes that the barrier to systems improvements in health care is 
not the lack of reporting mechanisms but the tort-induced reluctance of 
participants to provide data through the existing avenues. There is no 
indication that there are not enough reporting requirements. The Report 
describes them comprehensively. The need is to make the changes necessary to 
encourage more reporting, and for the agencies and institutions to which reports 
are made to analyze the information and act on them more vigorously. 
HCLA questions, therefore, whether any purpose would be served by adding 
new reporting requirements or creating new agencies to collect or coordinate 
reports. In fact, adding new reporting requirements would only distract 
attention from the need to make the essential tort changes to support the 
existing reporting requirements. 
No new reporting requirements without 
confidentiality 
While recognizing that the barrier to existing reporting 
requirements is a lack of confidentiality and fear of the tort system, the 
Report does not address this barrier, except in its recommendation that peer 
review protections be expanded. 
Instead it recommends that mandatory 
reporting of serious adverse events be expanded by federal statute, without 
corresponding confidentiality protection. Indeed. while it offers a gesture 
toward the states' role, it would make mandatory reporting a federal requirement 
in any state that did not on its own come to the conclusion that mandatory 
reporting is needed.25 Although The Report recognizes that the absence of 
confidentiality is impeding compliance with existing reporting requirements, it 
would make mandatory reporting a national requirement while providing no 
confidentiality protection. 
The Report would permit confidentiality 
protection only for voluntary reporting of events that are not serious--where it 
is least useful. 
If an event results in little or no harm, there 
may be less concern about tort litigation. The Report offers confidentiality 
protection here, where it is worth less, but would deny it in the serious cases, 
where it is important to elicit reporting. Recommending confidentiality for 
voluntary reports is not a sufficient response to the problem identified by the 
Report itself--that lack of confidentiality deters reporting. 
Drawing a 
line, moreover, on when reporting is required and when it is confidential on the 
basis of whether the action resulted in "serious" harm will bog down the health 
care system in line-drawing and hair- splitting. What is serious harm? Who 
defines it? Suppose the event could have had a serious harm if it had not been 
caught? How long is serious? Is an extra day in a hospital serious? Is a false 
positive that leads to patient concern serious? Suppose the patient was not able 
to understand the test result; is a false positive serious in that case?26 
Rather than trying to impose reporting by regulation and mandates, and 
varying the protection for different types of reports, Congress should provide 
protection for all safety and quality reports, and for consideration of them. 
This is the best way to advance patient safety efforts. 
No 
centralization of safety efforts 
It would be both unnecessary and 
harmful to create the new Federal Center proposed in the IOM Report. The Report 
envisages various roles for this new Center. HCLA believes these are unnecessary 
and would actually detract from efforts to improve patient safety. 
The 
Report sees a need for the Center to establish a "national focus to create 
leadership, research, tools, and protocols to enhance the knowledge base about 
safety."2? The premise that only the creation of a government Center can create 
a national focus and provide leadership is disturbing. 
As the Report 
indicates, efforts to enhance patient safety are being undertaken in different 
ways by a variety of individuals and institutions: insurers, manufacturers, 
providers, academic institutions, trade associations, etc. It may look messy and 
confused, but the pursuit of knowledge often is, particularly in an area as 
complex and varied as the design and manufacture of health care products and the 
delivery of health care. 
Commissions, meetings, and public awareness can 
all contribute to a national focus. So can efforts by political leaders, if 
conducted without demagogy and finger pointing. A new Center is not necessary to 
do this. This proposal is really symbolic; concern would be demonstrated by 
creating a new Center and spending more money. 
An approach based on 
centrally developing and collecting safety- related data could in fact impair 
safety research and promotion of safety activities. A centralized agency for 
safety research could well become hitched to a particular view or approach, 
subordinating all others. It is more effective for different people to try 
different approaches. 
Creating a "highly visible (governmental) center" 
is likely not only to diminish the diversity of research and views but to 
politicize patient safety. Once there is a "highly visible" government agency 
tasked to provide leadership and develop research and recommendations, every 
interest group will descend on it in an effort to gets its agenda adopted. 
Congress will inevitably be drawn in. It would be far more effective, if more 
research is needed, to provide funding to a variety of researchers on a 
scientific, non-political basis.The Report also has another role in mind for the 
new Federal safety Center. It would not be limited to research. It would receive 
and analyze reports (from the states)-apparently the mandatory reports of 
"serious adverse events" discussed above. The Center would become a national 
data bank for at least some kinds of reports. But it is unclear how the 
information would be used and who would have access to it. The Center apparently 
would "identify persistent safety issues that require more intensive analysis 
and/or a broader-based response."28 In other words, it would use the data to do 
more studying. But would the agency act on the information? To whom would it 
give its findings? 
What is needed is not central collection of 
information, nor more analysis and dissemination. Needed information should be 
given to those in a position, and with the most powerful incentive, to use it to 
improve patient safety. Instead of funneling data through a centralized, and 
possibly politicized, government agency, the focus should be on doing what is 
necessary to get the information to those who will actually use it to improve 
patient safety. 
Hospitals need more information about errors that are 
made there. Licensing boards need more information about their licensees. It is 
far simpler, and more effective. to inform a device manufacturer that the 
labeling is confusing than to report this to Washington. With this information, 
manufacturers, providers, and insurers would have the greatest incentive and the 
best ability to use it to improve safety. 
Instead of creating a 
centralized, nation-wide, government-led reporting system. we should focus on 
doing what is necessary to get more information to the people on the front lines 
of health care quality. 
Compliance will be enhanced if reporters know 
they are reporting to an entity that will use the information effectively. A 
nurse is far more likely to report an error to her nursing supervisor or to 
report a problem with a device to its manufacturer than to file a form destined 
for a distant Federal bureaucracy. Health care providers are the people who are 
most concerned with quality of care and patient safety. They are more personally 
and directly concerned than is a distant government bureau. They strongly want 
to avoid adverse events. They want to provide good care. 
There is 
another practical factor that must be considered. Providers function under 
conditions of considerable stress. They are quite astute in distinguishing 
between what is real and what is more government make-work. They are more likely 
to report when they believe it will do good (particularly if they have 
protections of confidentiality) than where they are told to fill out another 
government-imposed form that seems to bear little or no relation to their real 
world--patient care. 
Providers, manufactures, suppliers, employers who 
sponsor health plans, and insurers, deal with each other and with various 
licensing and quality institutions on an ongoing basis. They should be 
encouraged to report potential or existing problems and discuss improvements 
among themselves. This can best be achieved by protection of confidentiality for 
reports and discussions, and by reform of the tort system. Requirements that 
they file reports with a state agency for forwarding to Washington, D.C., will 
not encourage reporting or enhance collaborative efforts to improve the quality 
of care. 
CONCLUSION 
The IOM Report documents the obstacles to 
greater patient safety efforts: the difficulties in securing more reporting that 
result from the lack of confidentiality and the shadow cast by the litigation 
system. But rather than addressing these problems, it recommends more reporting 
(but without confidentiality) and centralizing the reporting system. 
The 
problem, however, is not a lack of centralized reporting; it is the barriers to 
reporting and to safety-improvement measures posed by the tort system. 
The problem is not a lack of reporting mechanisms, but a lack of assured 
confidentiality and fear on the part of the people who would report that they 
will be enmeshed in the litigation system. 
The primary need is not more 
data and more studies; it is for those in the field attempting to improve 
patient safety to have confidence that cooperating in safety improvement 
measures will not result in involvement in burdensome tort litigation. 
The fears induced by the tort system cannot be resolved by expanding the 
already unsuccessful requirements to report. The problems of the tort system 
itself must be addressed. 
The solution should not be centralized or 
governmental; it should be private and dispersed. Medical errors, when they 
occur, happen at the local level, and local solutions are best crafted to solve 
local problems. 
The quality of health care, consequently, can best be 
improved by reforming the tort system to: 1) reduce the number of lawsuits, 2) 
make the system more fair and efficient, and 3) reduce its costs. 
Reforms in this direction would lessen the pressures to practice 
defensive medicine, lower health care costs, and increase access to care. At the 
same time, a fairer and less random tort system, and assurances of 
confidentiality, would reduce the barriers to reporting and enhance the ability 
of the field to identify problems and to make corrections. 
FOOTNOTES: 
l Jeffrey O'Connell, "Two-Tier Tort Law: Neo No-Fault & 
Quasi-Criminal Liability," 27 Wake Forest Law Review 871 (1992). 
2 
Richard E. Anderson, "Billions for Defense," Archives of Internal Medicine. 
1999; 159:2401 
3 Paul Weiler et al., A Measure of Malpractice. 
Cambridge: Harvard University Press; 1993. 
4 Troyen A. Brennan et al, 
"Relation Between Negligent Adverse Events and the Outcomes of 
Medical-Malpractice Litigation," N Engl J Med 1996; 335:1963-7. 
5 Ibid. 
6 David Kessler and Mark McClellan, "Do Doctors Practice Defensive 
Medicine," QJ Econ. 1996; 111: 353-390. 
7 Jeffrey O'Connell and C. Brian 
Kelly, The Blame Game. Lexington Books; 1987:127. Berkeley Rice, "Do doctors 
kill 80,000 patients a year'?" Medical Economics. November 21, 1994; 
8 
(discussing extrapolation to 80,000 deaths). 
9 Troyen Brennan et al., 
"Incidence of Adverse Events and Negligence in Hospitalized Patients: Results of 
the Harvard Medical Practice Study," N Eng. J Med 1991; 324: 370-6. 
10 
"Billions for Defense" at 2400. The second set of reviewers found the same 
incidence of adverse events and adverse events due to negligence, but not in the 
same charts. Rather than confirming the reliability of the methodology used, 
this provides further demonstration of the uncertainty of what is an adverse 
event and what is negligence. 
11 "To Err is Human" at 1, 22. 
12 
A Measure of Malpractice at 138. 
13 "To Err is Human" at 42. 
14 
Id. at 4. 
15 Id. at 47. 
16 Id. at 37. 
17 Id. at 85. 
18 Id. at 94. 
19 Id. at 105. 
20 Id. at 9. 
21 Id. 
at 103-104. 
22 As the Report recognizes, "One legal fear is that 
disclosure of internal quality data to outside reviewers not under a peer review 
statute will lead to discovery, from JCAHO in lawsuits; indeed, many fear that 
disclosure to JCAHO would invalidate even the nondiscoverability protections 
each hospital enjoys for its own data under its state peer review statute." Id. 
at 108. 
23 Id. at 96. 
24 Id. at 9. 
25 Id. at 8. 
26 Unintentionally demonstrating the problem, the Report also refers to 
the kinds of acts that would fall under the voluntary (and confidential) 
reporting scheme as ones that resulted in "no harm...(near misses) or very 
minimal patient harm." (p. 74) What is supposed to be done with respect to 
injuries that fall between serious and minimal. 
27 "To Err is Human" at 
5. 
28 Id. at 76. 
END 
LOAD-DATE: 
February 15, 2000